hotspot -WSS

hotspot

author：leisure time 2025-10-01 14:40:31 - browse：46

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Laying a path for careers in science

leisure time

WSS

CDC advisory group OKs chikungunya vaccine

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

STAT Madness 2024: Meet the contenders

DeSantis talks Trump, trans issues and 'what wokeness is'

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Ohio train derailment: Experts on toxic chemical risks

focus

hotspot

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Childhood vaccination ad campaign launches in the U.K.

The cancer drug shortage isn’t new — and neither are the solutions

CDC panel: People 65 and older should get a Covid spring booster shot

In age of alternative facts, a scholarly course on calling out crap

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Walensky prepares to leave CDC — and Congress — behind

Childhood vaccination ad campaign launches in the U.K.

In age of alternative facts, a scholarly course on calling out crap

Tocagen's brain cancer gene therapy trial continues. Investors worry

hotspot

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Cholera vaccine supplies dangerously low, outbreaks surging

Children’s Hospital revives plan for pedestrian bridge

Cholera vaccine supplies dangerously low, outbreaks surging

Pfizer is about to make a big push in cancer. Will investors listen?

DeSantis talks Trump, trans issues and 'what wokeness is'

focus

leisure time

entertainment

explore